Review of the Federal Bureau of Prisons' Pharmaceutical Drug Costs and Procurement
- NARA ID
- review-federal-bureau-prisons-pharmaceutical-drug-costs-and-procurement
- Source
- oig-doj
- Collection
- DOJ OIG — Federal Bureau of Prisons
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Inspection / Evaluation
- Released
- 2020-02-20
- Slug
- doj-oig-review-federal-bureau-prisons-pharmaceutical-drug-costs-and-procurement
- Indexed
- 2026-04-27 05:04:10
More from DOJ OIG — Federal Bureau of Prisons
- Notification of Concerns Regarding Federal Bureau of Prisons' Policies Pertaining to Special Housing Unit Logs Used to Record Mandatory Rounds and the Retention Period for the Original Logs
- Remote Inspection of Federal Correctional Institution Milan
- Management Advisory Memorandum: Notification of a Need to Heighten Awareness of and Compliance with Laws and Regulations Relating to Procurements from Foreign Countries
- Investigative Summary: Findings of Misconduct by a Former Federal Bureau of Prisons Office Chief for Violating Policy Regarding Pilot Initiatives
- Audit of the Federal Bureau of Prisons' Residential Reentry Center Contracts Awarded to Reynolds & Associates, Inc., Washington, D.C.
- Remote Inspection of the CORE Services Group, Inc.’s Brooklyn House Residential Reentry Center, Brooklyn, New York
Browse all 159 documents in DOJ OIG — Federal Bureau of Prisons →
About the DOJ OIG — Federal Bureau of Prisons collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning Federal Bureau of Prisons.